Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
about
Multiple Sclerosis Pathology: Evolution of Pathogenetic ConceptsAlzheimer's disease as homeostatic responses to age-related myelin breakdownAtacicept: targeting B cells in multiple sclerosisTheiler's virus infection: a model for multiple sclerosisCX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin.Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple SclerosisCNS Remyelination and the Innate Immune SystemRemyelination therapy for multiple sclerosisProgressive multiple sclerosisNew aspects of the pathogenesis of canine distemper leukoencephalitisAntibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating DiseaseInflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple SclerosisClinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosisThe immunopathology of multiple sclerosis: an overviewFabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoidsNano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative DiseasesThe impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trialsNogo-receptors NgR1 and NgR2 do not mediate regulation of CD4 T helper responses and CNS repair in experimental autoimmune encephalomyelitisOestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Models of autoimmune demyelination in the central nervous system: on the way to translational medicine.Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells.Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.Diffusion tensor magnetic resonance imaging in patients with multiple sclerosis and its relationship with disabilityMultifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship.Thalamus pathology in multiple sclerosis: from biology to clinical application.Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imagingResting state sensorimotor functional connectivity in multiple sclerosis inversely correlates with transcallosal motor pathway transverse diffusivity.MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain.Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.Glatiramer acetate: evidence for a dual mechanism of action.Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry.Myelin recovery in multiple sclerosis: the challenge of remyelinationAxonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus.Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosisDecreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells.Radial diffusivity in remote optic neuritis discriminates visual outcomes.Energy failure in multiple sclerosis and its investigation using MR techniques.
P2860
Q22242303-985DFE30-E2A5-431A-90FA-488E027EA3BFQ22251261-49FC8E9D-0862-46E4-A51B-7C46873D0AC0Q24628925-948BFA28-2E1E-4B23-8803-C0181D16B7A2Q24629115-8CA55B53-3FE3-4565-A9B0-04F45E4D32BDQ24814510-E6BBF6A1-61A2-49E9-BBC4-5A445BD90D37Q26744629-DA056DD1-D54A-4884-B18F-AD4AC83B9495Q26747242-4FF762E2-9C70-465A-BDB7-48FE5D1A5996Q26824246-91A65A2E-8491-4066-91C9-6D74953AFED9Q26861772-79D3DCC1-09E8-4987-917A-6304198A2C97Q27026660-41750229-4099-4F67-86AA-44148A5891C0Q28080515-122D842B-5FEB-43A7-A585-719B407EC224Q28080754-7ABC3273-5DED-484F-AF3E-3CD30E907F61Q28275482-370A0505-1A16-467E-82AA-9DC5ABBFBD3DQ28295115-C0085A47-7F23-4F70-9788-96B9915F7FC9Q28477392-22B3FA5F-C9B8-4C93-A599-3E79A5FA4404Q28546214-E6C4BEE8-DA29-489C-B8B4-3912D422B0DCQ28741521-1FA44CF7-1F14-40A4-A9F0-EA5BE5CA0077Q28742885-EC0A8850-FD2C-458C-9BB0-092735FFC37BQ30479247-DD5CAB26-A8BF-40B0-A3E2-4E5BEF2499A7Q30483471-B9EA4DBA-EAF9-48CB-9118-204A6835C7EDQ30495914-772E2426-91C7-401F-96BF-58AB74CF77CAQ30501593-4612A193-2099-46AE-B5EE-54A136651B7EQ30655532-E3F54C44-F25B-40F7-B39F-F7E95C5E3229Q30847634-1B352B63-307D-484B-A6E3-DF9FDFB74D89Q30871067-9861B330-7A1D-4BC4-ABCC-5411F225EF64Q31104509-45FE5E41-9F77-4562-A4B9-8D7872AA9C71Q31139925-9A7CAC58-2E6C-4E74-8566-C8FED6C35E6BQ31140002-6EAC86CB-1102-46E8-BB4F-8AA7BE5561DAQ31153713-4291A723-76F3-487D-B016-768005C18513Q33211281-CF96FBA2-5C28-4FD8-A32B-0611B6A7C684Q33211930-CCAB7D67-CD3F-4100-8063-5BEE3F6183B5Q33345291-E6CBB822-50E0-43A8-B5C8-486EAFE1D91DQ33367115-20F24227-F6E6-4727-BA7C-3A441D65F554Q33556095-76F37A7A-F0ED-4577-AFE1-5FED361658B1Q33772195-7C86C8C7-1EC5-44C4-924A-38CE9F77FBD4Q33842565-03195E02-0C7A-4EE4-A912-9B7CE6D6AB0AQ33869433-45AB415C-280C-4859-9422-8B29ADA9A79BQ33872546-1C59F87E-C094-4CF0-AC4F-7AF5BA328DD5Q33899862-91AE936D-AC43-485C-A7A8-7B3E52513943Q33928808-98C6A5D4-70C0-46F8-8641-883C8015CFC8
P2860
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@ast
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@en
type
label
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@ast
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@en
prefLabel
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@ast
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@en
P2093
P2860
P1476
Multiple sclerosis and chronic ...... ive, and remyelinated lesions.
@en
P2093
A Stefferl
C Linington
E Wallstroem
H Lassmann
M K Storch
M Schmidbauer
R Weissert
P2860
P304
P356
10.1016/S0002-9440(10)64537-3
P407
P50
P577
2000-07-01T00:00:00Z